1.1900
+0.0900
+(8.18%)
As of 2:25:27 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AZELBY ROBERT W Director | Sale | Jun 17, 2024 | 53,005 |
| BIZZARI JEAN-PIERRE Director | Sale | Jun 17, 2024 | 79,502 |
| CARMONA JOSE Chief Financial Officer | Stock Award(Grant) | Feb 13, 2025 | 541,892 |
| GRAHAM PETER J Officer | Stock Award(Grant) | Feb 13, 2025 | 408,542 |
| KALLEBO LISA MICHELLE Officer | Stock Award(Grant) | Feb 13, 2025 | 77,897 |
| MALLIK AMEET Chief Executive Officer | Stock Award(Grant) | Feb 13, 2025 | 1,579,000 |
| REDMILE GROUP, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 11, 2024 | -- |
| SANDOR VICTOR Director | Sale | Jun 17, 2024 | 80,886 |
| SQUARER RON R Director | Sale | Jun 17, 2024 | 80,663 |
| ZAKI MOHAMED Officer | Stock Award(Grant) | Feb 13, 2025 | 462,888 |
Related Tickers
KURA Kura Oncology, Inc.
6.07
+8.01%
PASG Passage Bio, Inc.
0.3898
+19.26%
SNDX Syndax Pharmaceuticals, Inc.
11.76
+11.36%
ALEC Alector, Inc.
1.0200
+8.25%
AUTL Autolus Therapeutics plc
1.2250
+3.81%
FDMT 4D Molecular Therapeutics, Inc.
2.8800
+14.74%
ENTA Enanta Pharmaceuticals, Inc.
4.6100
+3.36%
SYRE Spyre Therapeutics, Inc.
13.51
+14.49%
SLN Silence Therapeutics plc
2.4500
+6.52%
CGEM Cullinan Therapeutics, Inc.
8.01
+9.43%